Worldwide Clinical Trials

FEBRUARY 26, 2024

With the necessary prioritization of various factors when designing your clinical trial, the patient experience can be overlooked or improperly addressed in study design. However, incorporating the patient experience into your design is one of the best ways to ensure your drug development program is a commercial success.

Clinical Trials 137

Clinical Trials Clinical Trials Trials Clinical Research 137

BioTech 365

OCTOBER 14, 2020

Press release, Helsinki, 14 October 2020 at 10.00 (EEST) Nexstim Podium Webinars Demonstrate How Nexstim Systems Have Advanced the Standard of Care for Patients Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces that the Nexstim Podium live webinar series, launched … Continue reading →

40

40

Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar.

Marketing 264

Marketing Vaccination Vaccine Development 264

Worldwide Clinical Trials

OCTOBER 26, 2022

Having worked in psychedelic research since the advent of industry-sponsored trials, Worldwide Clinical Trials has amassed the expertise needed to execute these studies successfully, recently sharing insights in a webinar titled “ Demystifying Complex Operations in Psychedelic Research ,” available on-demand now.

Trials 243

Trials Clinical Trials Clinical Trials Licensing 243

Rethinking Clinical Trials

FEBRUARY 28, 2023

The Society for Medical Decision Making (SMDM) will host a free, live webinar on Thursday, March 2, to discuss equity and patient engagement. The webinar, “Equity in Medical Decision Making: Perspectives from Patient Partners and SMDM Members,” was organized by the SMDM Patient Advisory Council.

Medicine 130

Medicine Life Science Clinical Trials Clinical Trials 130

BioTech 365

NOVEMBER 9, 2020

Patient-centered Engagement Tools, Effective Specialty Rx Communications: Self-Insured Employers, Plan Sponsors Learn from Industry Experts — Episode 3, AscellaHealth Educational Webinars Patient-centered Engagement Tools, Effective Specialty Rx Communications: Self-Insured Employers, Plan Sponsors Learn from Industry Experts — Episode (..)

40

40

BioTech 365

JUNE 16, 2021

Sequana Medical to Host a Key Opinion Leader Webinar on “The Impact of Liver Ascites on Patients and Healthcare Systems and the potential of alfapump® therapy in NASH-related ascites” Sequana Medical to Host a Key Opinion Leader Webinar on “The … Continue reading →

40

40

Drug Channels

JANUARY 16, 2024

My recent Drug Channels Outlook 2024 webinar covered 12 key trends that will shape the commercial environment this year. As I explain, this growth will challenge payer and channel economics, while boosting profits for patient reimbursement hub businesses and pharmacy benefit managers (PBMs). My first webinar will be on April 5, 2024.

Drugs 81

Drugs Pharmacy Production 81

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. This event is part of The Drug Channels 2024 Video Webinar Series.

Drugs 85

Drugs Pharmacy Marketing Branding 85

Outsourcing Pharma

JULY 1, 2021

On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.

59

59

Antidote

OCTOBER 12, 2022

On October 4, Antidote’s Senior Clinical Informatics Manager Dr. Rich Towne participated in a community education webinar for the North Carolina chapter of Lung Cancer Initiative. This webinar was aimed at educating lung cancer patients and professionals in the lung cancer industry on clinical trials and recent advancements in the field.

Clinical Trials 98

Clinical Trials Clinical Trials Trials 98

Drug Channels

AUGUST 1, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. Click here if you can’t see the video below. d/b/a Drug Channels Institute.

Manufacturing 78

Manufacturing Drugs Marketing 78

CTTI (Clinical Trials Transformation Initiative)

FEBRUARY 8, 2024

CTTI will host a free public webinar on Thursday, Feb. This can naturally lead to better decision-making, treatment options, and outcomes for patients. Register for the free 60-minute webinar. 29 at 12:00 p.m. The post CTTI to Launch New Embedding Trials Feasibility Assessment Tool appeared first on CTTI.

Trials 60

Trials Clinical Trials Clinical Trials Development 60

Pharma Mirror

JANUARY 23, 2023

This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

Clinical Trials 147

Clinical Trials Clinical Trials Trials Clinical Research 147

Drug Channels

OCTOBER 5, 2023

IMHO, this was a huge win for patients thanks to the HIV + Hepatitis Policy Institute, the Diabetes Patient Advocacy Coalition, and the Diabetes Leadership Council. I then follow the dollar to show how they impact plan, patient, and manufacturer costs when compared with traditional approaches to copay support.

Manufacturing 77

Manufacturing Drugs Marketing 77

Worldwide Clinical Trials

JUNE 15, 2022

At the end of May, we hosted a webinar titled “ Changing Times, Changing Therapies: Keeping Up with Advancements in Cell and Gene Therapies ” to provide a quick update on the latest advancements and ongoing in development of these advanced therapeutics. We need to consider how to use diverse populations in gene therapy trials.

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

Drug Discovery World

SEPTEMBER 26, 2023

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The post Webinar: How AI is transforming drug discovery appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Protein Medicine 52

XTalks

FEBRUARY 23, 2024

Rare Disease Day is a global observance held on the last day of February each year that is aimed at raising awareness among the general public and decision-makers about rare diseases and their impact on patients’ lives. Rare Disease Day 2024 falls on February 29 this year as this year is a leap year, making the day even more rare and special.

Clinical Trials 103

Clinical Trials Clinical Trials Genetics Trials 103

Drug Discovery World

OCTOBER 5, 2023

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST.

Drugs 52

Drugs Protein Medicine 52

Drug Discovery World

SEPTEMBER 18, 2023

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST.

Drugs 52

Drugs Protein Medicine 52

Drug Discovery World

FEBRUARY 22, 2024

Ian Scanlon will discuss bottlenecks in advanced therapeutic delivery and how novel technologies can improve patient access and deliver sustainable processes.

Gene Therapy 52

Gene Therapy Gene RNA Scientist 52

Velocity Clinical Research

FEBRUARY 19, 2024

How can one specialist’s deep therapeutic expertise transform the way 90+ sites worldwide operate and engage patients? Since January, our Therapeutic Area Thursday webinars have also featured experts like Beth Safirstein, MD (Neurology), William Beacham, MD (Women’s Health and Pediatrics), and David Erb, MD (Pulmonary Medicine).

Trials 52

Trials Clinical Trials Clinical Trials Medicine 52

XTalks

JANUARY 16, 2024

There are other challenges facing CNS drug development, for example, higher-than-average patient drop-out rates due to the burden associated with attending clinical site visits. Barnum articulates a core issue: the variability in a patient’s condition.

Development 122

Development Drugs Clinical Trials Clinical Trials 122

Drug Discovery World

FEBRUARY 15, 2024

Ian Scanlon will discuss bottlenecks in advanced therapeutic delivery and how novel technologies can improve patient access and deliver sustainable processes.

Gene Therapy 52

Gene Therapy Gene RNA Scientist 52

Clinical Trial Gurus

JANUARY 1, 2021

Sites can improve their ability to recruit patients by relying on recruiters, services, or through referring physicians. Using physicians can be challenging for some sites most physicians are not interested in clinical research and will need to learn more about it before they can refer.

Clinical Research 52

Clinical Research Research 52

CTTI (Clinical Trials Transformation Initiative)

MARCH 1, 2024

29 webinar unveiling a new tool that aids in assessing the feasibility of embedding clinical trial elements into clinical practice is now available. A recording of CTTI’s Feb.

Clinical Trials 56

Clinical Trials Clinical Trials Trials 56

Drug Discovery World

JANUARY 31, 2024

Ian Scanlon will discuss bottlenecks in advanced therapeutic delivery and how novel technologies can improve patient access and deliver sustainable processes.

Gene Therapy 52

Gene Therapy Gene RNA Scientist 52

Outsourcing Pharma

JULY 9, 2021

During the Rare/Orphan Diseases, Special Patient Population webinar, a group of industry experts discussed challenges and opportunities faced in the field.

Research 103

Research Clinical Development Development 103

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing. and 12.4.3.

Pharmacy 75

Pharmacy Generic Drugs Drugs Marketing 75

pharmaphorum

OCTOBER 25, 2022

During the six-week-long trial, patients’ fear of movement had reduced significantly, their quality of life had improved, and perceived impression of change towards better significantly improved. The webinar includes thoughts and experiences from our side, as well as from our customer, Sammeli Liikkanen from Orion Corporation.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Medicine 98

XTalks

APRIL 3, 2024

Approximately ten to 20 percent of patients with PNH may develop extravascular hemolysis (EVH), a condition that causes RBC destruction outside of blood vessels. The complication occurs in these patients after the use of C5 inhibitors because C5 inhibition enables RBCs to survive and circulate.

FDA Approval 102

FDA Approval Sales Trials Development 102

Pharmaceutical Technology

OCTOBER 26, 2022

On October 6, in a GlobalData webinar, experts tried to answer the question ‘ Is Pharma at an ESG turning point?’ , revealing a multitude of diverse strategies for pharmaceutical companies to remain conscious of their global impacts. Research presented at GlobalData’s webinar supported this data. Click here to watch the full webinar.

Clinical Trials 162

Clinical Trials Clinical Trials Trials Life Science 162

Drug Channels

JUNE 22, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing.

Pharmacy 89

Pharmacy Generic Drugs Drugs Marketing 89

Drug Channels

AUGUST 4, 2023

Jonas describes the challenges patients face when accessing specialty therapies and explains how patient abandonment affects manufacturers over time. He argues that an effective telemedicine program can help patients via an end-to-end digital experience. To learn more, register for Phil’s free webinar on August 29th at 2 p.m.

Manufacturing 78

Manufacturing Production Drugs 78

XTalks

MARCH 19, 2024

Additionally, traditional clinical studies fail to objectively assess cognitive function as part of patient eligibility criteria or stratify patients according to the presence or degree of cognitive impairment. For instance, Dr. Milanovic underlines the common occurrence of patients underreporting or overreporting their symptoms.

Drugs 115

Drugs Clinical Trials Clinical Trials Clinical Research 115

XTalks

FEBRUARY 9, 2023

Leading clinical trials technology platform provider Medable announced a new partnership with Nova Scotia Health Innovation Hub for a two-year pilot study to improve oncology trial access for patients in rural Nova Scotia through Medable’s decentralized clinical trial (DCT) platform. Nova Scotia is Canada’s second smallest province by area.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

Drug Discovery World

FEBRUARY 5, 2024

Ian Scanlon will discuss bottlenecks in advanced therapeutic delivery and how novel technologies can improve patient access and deliver sustainable processes.

Gene Therapy 52

Gene Therapy Gene Marketing RNA 52